HOLX is leaning into international growth with Surgical division strength and untapped demand driving momentum abroad.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable ...

BlackRock's iShares Ethereum Trust has reached $10 billion, faster than all but two funds in the ETF industry's 32-year ...

Cognition is seeking to achieve a jaw-dropping $10B valuation as investors race to back the next big thing. Can its ...

The prefilled, patient-ready-to-use system is said to support delivery of high-viscosity biologics of up to 50 centipoise.

The S&P 500 and Nasdaq traded near all-time highs at midday as a strong earnings report from Alphabet lifted big tech stocks.